G. Bradley Cole, General Manager - Diagnostics at EXACT SCIENCES CORP (EXAS), sold 27,356 shares at $100.00 ($2.7M) on 2020-02-19, disclosed to the SEC on 2020-02-21.
Open-market sale of $2.7M EXAS by General Manager - Diagnostics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |
| GHDX | SELL | 2019-10-09 | $3.1M | — | Filing → |